Hypoxia-induced tumor malignancy and drug resistance: Role of microRNAs
Authors:
- Wan-Lin LiaoWLWan-Lin Liao
- Shao-Chieh LinSLShao-Chieh Lin
- H. Sunny SunHSH. Sunny Sun
- Shaw-Jenq TsaiSTShaw-Jenq Tsai
- 1 March 2014
- journal article
- Published by Elsevier in Biomarkers and Genomic Medicine
- Vol. 6 (1) , 1-11
Abstract
No abstract availableKeywords
Funding Information
- National Research Program for Biopharmaceuticals (NSC 101-2325-B-006-017)
- National Health Research Institute (NHRI-EX-102-10244BI)
This publication has 111 references indexed in Scilit:
- MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell linesCell Death & Disease, 2013
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive reviewEMBO Molecular Medicine, 2012
- Overexpression of Pyruvate Dehydrogenase Kinase 3 Increases Drug Resistance and Early Recurrence in Colon CancerThe American Journal of Pathology, 2011
- Hypoxia-Inducible Factors and the Response to Hypoxic StressMolecular Cell, 2010
- Posttranscriptional Regulation of MicroRNA Biogenesis in AnimalsMolecular Cell, 2010
- Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cellsJournal of Cancer Research and Clinical Oncology, 2010
- Lin28 Mediates the Terminal Uridylation of let-7 Precursor MicroRNAMolecular Cell, 2008
- miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cellsInternational Journal of Cancer, 2008
- FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancerThe Journal of Pathology, 2007
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007